Tom Wickham
Chief Scientific Officer GentiBio
Seminars
Thursday 17th September 2026
Engineering Cellular Shielding to Reduce Allogeneic Rejection
11:25 am
- Targeting genes that drive immune mediated rejection to protect therapeutic cells
- Applying multi gene knockout approaches to combat complex immune responses and reduce rejection risk
- Evaluating the impact of cellular shielding on long term persistence to demonstrate sustained efficacy and improved patient outcomes
